Identification of a novel enhancer essential for Satb1 expression in T H 2 cells and activated ILC2s
Life Science Alliance · 2023
DOI: 10.26508/lsa.202301897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2023. Verfasst von Aneela Nomura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan. Hauptthemen laut MEDLINE: Matrix Attachment Region Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitsubishi Foundation, Ministry of Education, Culture, Sports, Science and Technology, RIKEN’s Gender Equality Program.
Abstract (Originalsprache)
The genome organizer, special AT-rich binding protein-1 (SATB1), functions to globally regulate gene networks during primary T cell development and plays a pivotal role in lineage specification in CD4 + helper-, CD8 + cytotoxic-, and FOXP3 + regulatory-T cell subsets. However, it remains unclear how Satb1 gene expression is controlled, particularly in effector T cell function. Here, by using a novel reporter mouse strain expressing SATB1-Venus and genome editing, we have identified a cis -regulatory enhancer, essential for maintaining Satb1 expression specifically in T H 2 cells. This enhancer is occupied by STAT6 and interacts with Satb1 promoters through chromatin looping in T H 2 cells. Reduction of Satb1 expression, by the lack of this enhancer, resulted in elevated IL-5 expression in T H 2 cells. In addition, we found that Satb1 is induced in activated group 2 innate lymphoid cells (ILC2s) through this enhancer. Collectively, these results provide novel insights into how Satb1 expression is regulated in T H 2 cells and ILC2s during type 2 immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan.
- Laboratory for Innate Immune Systems, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan.
- Laboratory for Immune Crosstalk, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan.
- Laboratory for YCI Laboratory for Immunological Transcriptomics, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan.
- Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences(IMS), Yokohama, Japan.
- Laboratory for Innate Immune Systems, Department of Microbiology and Immunology, Graduate School for Medicine, Osaka University, Osaka, Japan.
ORCID-Profile: Aneela Nomura, Wooseok Seo, Michiko Ohno-Oishi, Ichiro Taniuchi
Förderung
- Mitsubishi Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN’s Gender Equality Program
Zitieren
APA
Nomura, A., Kobayashi, T., Seo, W., Ohno-Oishi, M., Kakugawa, K., Muroi, S., Yoshida, H., Endo, T. A., Moro, K., & Taniuchi, I. (2023). Identification of a novel enhancer essential for Satb1 expression in T H 2 cells and activated ILC2s. Life Science Alliance. https://doi.org/10.26508/lsa.202301897
Vancouver
Nomura A, Kobayashi T, Seo W, Ohno-Oishi M, Kakugawa K, Muroi S, et al. Identification of a novel enhancer essential for Satb1 expression in T H 2 cells and activated ILC2s. Life Science Alliance. 2023. doi:10.26508/lsa.202301897
BibTeX
@article{Nomura2023,
author = {Nomura, Aneela and Kobayashi, Tetsuro and Seo, Wooseok and Ohno-Oishi, Michiko and Kakugawa, Kiyokazu and Muroi, Sawako and Yoshida, Hideyuki and Endo, Takaho A and Moro, Kazuyo and Taniuchi, Ichiro},
title = {Identification of a novel enhancer essential for Satb1 expression in T H 2 cells and activated ILC2s},
journal = {Life Science Alliance},
year = {2023},
doi = {10.26508/lsa.202301897}
}
EUVIMED